Verdelli, A.; Caproni, M.; Coi, A.; Corrà , A.; Degl’Innocenti, D.; Vasarri, M.; Quintarelli, L.; Volpi, V.; Cipollini, E.M.; Barletta, E.
Neutrophil Gelatinase-Associated Lipocalin as Potential Predictive Biomarker of Melanoma and Non-Melanoma Skin Cancers in Psoriatic Patients: A Pilot Study. Int. J. Mol. Sci. 2022, 23, 12291.
https://doi.org/10.3390/ijms232012291
AMA Style
Verdelli A, Caproni M, Coi A, Corrà A, Degl’Innocenti D, Vasarri M, Quintarelli L, Volpi V, Cipollini EM, Barletta E.
Neutrophil Gelatinase-Associated Lipocalin as Potential Predictive Biomarker of Melanoma and Non-Melanoma Skin Cancers in Psoriatic Patients: A Pilot Study. International Journal of Molecular Sciences. 2022; 23(20):12291.
https://doi.org/10.3390/ijms232012291
Chicago/Turabian Style
Verdelli, Alice, Marzia Caproni, Alessio Coi, Alberto Corrà , Donatella Degl’Innocenti, Marzia Vasarri, Lavinia Quintarelli, Valter Volpi, Emanuele Maria Cipollini, and Emanuela Barletta.
2022. "Neutrophil Gelatinase-Associated Lipocalin as Potential Predictive Biomarker of Melanoma and Non-Melanoma Skin Cancers in Psoriatic Patients: A Pilot Study" International Journal of Molecular Sciences 23, no. 20: 12291.
https://doi.org/10.3390/ijms232012291
APA Style
Verdelli, A., Caproni, M., Coi, A., Corrà , A., Degl’Innocenti, D., Vasarri, M., Quintarelli, L., Volpi, V., Cipollini, E. M., & Barletta, E.
(2022). Neutrophil Gelatinase-Associated Lipocalin as Potential Predictive Biomarker of Melanoma and Non-Melanoma Skin Cancers in Psoriatic Patients: A Pilot Study. International Journal of Molecular Sciences, 23(20), 12291.
https://doi.org/10.3390/ijms232012291
